| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9966 |
| Human Intestinal Absorption | HIA+ | 0.9952 |
| Caco-2 Permeability | Caco2+ | 0.6558 |
| P-glycoprotein Substrate | Substrate | 0.6489 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7390 |
| Inhibitor | 0.6548 |
| Renal Organic Cation Transporter | Inhibitor | 0.5819 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7119 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7819 |
| CYP450 2D6 Substrate | Non-substrate | 0.8422 |
| CYP450 3A4 Substrate | Substrate | 0.7404 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7760 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5458 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8090 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7949 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5085 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7781 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9836 |
| Inhibitor | 0.5729 |
| AMES Toxicity | Non AMES toxic | 0.8369 |
| Carcinogens | Non-carcinogens | 0.7657 |
| Fish Toxicity | High FHMT | 0.9348 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9846 |
| Honey Bee Toxicity | Low HBT | 0.8592 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | IV | 0.5780 |
| Carcinogenicity (Three-class) | Non-required | 0.6992 |